80 FR 62078 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 199 (October 15, 2015)

Page Range		62078-62079
FR Document		2015-26124

Federal Register, Volume 80 Issue 199 (Thursday, October 15, 2015)

[Federal Register Volume 80, Number 199 (Thursday, October 15, 2015)]
[Notices]
[Pages 62078-62079]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-26124]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel--Harnessing Genome Editing Technologies to 
Functionally Validate Genetic Variants in Substance Use Disorders 
(R21/R33).
    Date: November 6, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, 
Bethesda, MD 20814.
    Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 4234, MSC 9550, Bethesda, MD 02892, 301-443-9511, 
jrao@nida.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel--Phase II In-person Interview: NIDA Avant-Garde Award 
Program for HIV/AIDS Research (DP1).
    Date: December 1, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, 
Bethesda, MD 20814.
    Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
4238, MSC 9550, Bethesda, MD 20892, 301-402-6020, 
hiromi.ono@nih.gov.

Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)


[[Page 62079]]


    Dated: October 8, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-26124 Filed 10-14-15; 8:45 am]
 BILLING CODE 4140-01-P

62078 Federal Register / Vol. 80, No. 199 / Thursday, October 15, 2015 / Notices

Healthy People 2020 is the product of 3. Objectives should drive actions that Dated: October 9, 2015.
an extensive collaborative process that will work toward the achievement of the Don Wright,
relies on input from a diverse array of proposed targets (defined as quantitative Deputy Assistant Secretary for Health, Office
individuals and organizations, both values to be achieved by the year 2020). of Disease Prevention and Health Promotion.
within and outside the federal 4. Objectives should be useful and [FR Doc. 2015–26244 Filed 10–14–15; 8:45 am]
government, with a common interest in reflect issues of national importance. BILLING CODE 4150–32–P
improving the nation’s health. Public Federal agencies, states, localities, non-
comments were a cornerstone of governmental organizations, and the
Healthy People 2020’s development. DEPARTMENT OF HEALTH AND
public and private sectors should be
During the first phase of planning for HUMAN SERVICES
able to use objectives to target efforts in
Healthy People 2020, HHS asked for the
schools, communities, work sites, health National Institutes of Health
public’s comments on the vision,
practices, and other environments.
mission, and implementation of Healthy
People 2020. Those comments helped 5. Objectives should be measurable National Institute on Drug Abuse;
set the framework for Healthy People and should address a range of issues, Notice of Closed Meetings
2020. The public was also invited to such as: Behavior and health outcomes; Pursuant to section 10(d) of the
submit comments on proposed Healthy availability of, access to, and content of Federal Advisory Committee Act, as
People 2020 objectives, which helped behavioral and health service amended (5 U.S.C. App), notice is
shape the final set of Healthy People interventions; socio-environmental hereby given of the following meetings.
2020 objectives. conditions; and community capacity— The meetings will be closed to the
The public is now invited to comment directed toward improving health public in accordance with the
on new objectives proposed to be added outcomes and quality of life across the provisions set forth in sections
to Healthy People 2020. These new life span. (Community capacity is 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
objectives were developed by topic area defined as the ability of a community to as amended. The grant applications and
workgroups led by various agencies plan, implement, and evaluate health the discussions could disclose
within the federal government. They strategies.) confidential trade secrets or commercial
have been reviewed by the Federal property such as patentable materials,
6. Continuity and comparability of
Interagency Workgroup on Healthy and personal information concerning
measured phenomena from year to year
People 2020 and are presented now for individuals associated with the grant
the public’s review and comment. The are important, thus, when appropriate,
retention of objectives from previous applications, the disclosure of which
public is also invited to suggest would constitute a clearly unwarranted
additional objectives for consideration Healthy People iterations is encouraged.
However, in instances where objectives invasion of personal privacy.
that address critical public health issues
within existing Healthy People 2020 and/or measures have proven ill-suited Name of Committee: National Institute on
to the purpose or are inadequate, new Drug Abuse Special Emphasis Panel—
topic areas. Any proposed new objective Harnessing Genome Editing Technologies to
must meet all of the objective selection improved objectives should be
developed. Whether or not an objective Functionally Validate Genetic Variants in
criteria (see below). Substance Use Disorders (R21/R33).
Written comments will be accepted at has met its target in a previous Healthy Date: November 6, 2015.
http://www.healthypeople.gov/2020/ People iteration should not be the sole Time: 8:00 a.m. to 5:00 p.m.
about/history-development/Public- basis for retaining or archiving an Agenda: To review and evaluate grant
Comment during a 30-day public objective. applications.
Place: Hilton Garden Inn Bethesda, 7301
comment period beginning in October 7. The objectives should be supported
Waverly Street, Bethesda, MD 20814.
2015. The public will also be able to by the best available scientific evidence. Contact Person: Jagadeesh S. Rao, Ph.D.,
submit written comments via mail, fax, The objective selection and review Scientific Review Officer, Office of
and email (see contact information processes should be flexible enough to Extramural Affairs, National Institute on
above). Comments received in response allow revisions to objectives in order to Drug Abuse, National Institutes of Health,
to this notice will be reviewed and reflect major updates or new knowledge. DHHS, 6001 Executive Boulevard, Room
considered by the appropriate topic area 4234, MSC 9550, Bethesda, MD 02892, 301–
8. Objectives should address 443–9511, jrao@nida.nih.gov.
workgroup, Federal Interagency population disparities. These include
Workgroup on Healthy People 2020, and Name of Committee: National Institute on
populations categorized by race/ Drug Abuse Special Emphasis Panel—Phase
other Healthy People 2020 stakeholders. ethnicity, socioeconomic status, gender, II In-person Interview: NIDA Avant-Garde
Objective Selection Criteria disability status, sexual orientation, and Award Program for HIV/AIDS Research
geographic location. For particular (DP1).
The following nine criteria should be Date: December 1, 2015.
health issues, additional special
taken into consideration when Time: 8:00 a.m. to 5:00 p.m.
populations should be addressed, based
commenting on the proposed new Agenda: To review and evaluate grant
on an examination of the available
objectives or suggesting additional applications.
evidence on vulnerability, health status,
objectives. Place: Hilton Garden Inn Bethesda, 7301
1. The result to be achieved should be and disparate care. Waverly Street, Bethesda, MD 20814.
important and understandable to a 9. Healthy People 2020, like past Contact Person: Hiromi Ono, Ph.D.,
broad audience and support the Healthy versions, is heavily data driven. Valid, Scientific Review Officer, Office of
Extramural Affairs, National Institute on
mstockstill on DSK4VPTVN1PROD with NOTICES

People 2020 goals. reliable, nationally representative data
Drug Abuse, National Institutes of Health,
2. Objectives should be prevention and data systems should be used for
DHHS, 6001 Executive Boulevard, Room
oriented and should address health Healthy People 2020 objectives. Each 4238, MSC 9550, Bethesda, MD 20892, 301–
improvements that can be achieved objective must have (1) a data source, or 402–6020, hiromi.ono@nih.gov.
through population-based and potential data source, identified, (2) Catalogue of Federal Domestic Assistance
individual actions, and systems-based, baseline data and (3) assurance of at Program Nos.: 93.279, Drug Abuse and
environmental, health-service, or policy least one additional data point Addiction Research Programs, National
interventions. throughout the decade. Institutes of Health, HHS)

VerDate Sep<11>2014 17:19 Oct 14, 2015 Jkt 238001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\15OCN1.SGM 15OCN1

Federal Register / Vol. 80, No. 199 / Thursday, October 15, 2015 / Notices 62079

Dated: October 8, 2015. DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance
Michelle Trout, HUMAN SERVICES Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
Program Analyst, Office of Federal Advisory 93.337, 93.393–93.396, 93.837–93.844,
Committee Policy. National Institutes of Health
93.846–93.878, 93.892, 93.893, National
[FR Doc. 2015–26124 Filed 10–14–15; 8:45 am] Institutes of Health, HHS)
Center for Scientific Review; Notice of
BILLING CODE 4140–01–P Closed Meetings Dated: October 9, 2015.
Anna Snouffer,
Pursuant to section 10(d) of the
Deputy Director, Office of Federal Advisory
DEPARTMENT OF HEALTH AND Federal Advisory Committee Act, as Committee Policy.
HUMAN SERVICES amended (5 U.S.C. App.), notice is
[FR Doc. 2015–26228 Filed 10–14–15; 8:45 am]
hereby given of the following meetings.
BILLING CODE 4140–01–P
National Institutes of Health The meetings will be closed to the
public in accordance with the
National Institute of Allergy and provisions set forth in sections
Infectious Diseases; Notice of Closed 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., DEPARTMENT OF HOMELAND
Meeting as amended. The grant applications and SECURITY
the discussions could disclose Coast Guard
Pursuant to section 10(d) of the confidential trade secrets or commercial
Federal Advisory Committee Act, as property such as patentable material, [Docket No. USCG–2015–0694]
amended (5 U.S.C. App.), notice is and personal information concerning
hereby given of the following meeting. individuals associated with the grant Information Collection Request to
The meeting will be closed to the applications, the disclosure of which Office of Management and Budget;
public in accordance with the would constitute a clearly unwarranted OMB Control Number: 1625–0040
provisions set forth in sections invasion of personal privacy. AGENCY:Coast Guard, DHS.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Name of Committee: Center for Scientific Sixty-day notice requesting
ACTION:
as amended. The contract proposals and Review Special Emphasis Panel; Special comments.
the discussions could disclose Topics in HIV/AIDS Behavioral Research
confidential trade secrets or commercial Date: November 5, 2015. SUMMARY: In compliance with the
Time: 5:00 p.m. to 7:00 p.m. Paperwork Reduction Act of 1995, the
property such as patentable material,
Agenda: To review and evaluate grant U.S. Coast Guard intends to submit an
and personal information concerning applications.
individuals associated with the contract Place: Residence Inn Bethesda, 7335
Information Collection Request (ICR) to
proposals, the disclosure of which Wisconsin Avenue, Bethesda, MD 20814. the Office of Management and Budget
would constitute a clearly unwarranted Contact Person: Mark P Rubert, Ph.D., (OMB), Office of Information and
invasion of personal privacy. Scientific Review Officer, Center for Regulatory Affairs (OIRA), requesting an
Scientific Review, National Institutes of extension of its approval for the
Name of Committee: National Institute of Health, 6701 Rockledge Drive, Room 5218, following collection of information:
Allergy and Infectious Diseases Special MSC 7852, Bethesda, MD 20892, 301–435– 1625–0040, Application for Merchant
Emphasis Panel; HIV Staged Vaccine 1775, rubertm@csr.nih.gov. Mariner Credential (MMC), Application
Development (N01). Name of Committee: Center for Scientific for Merchant Mariner Medical
Date: November 3, 2015. Review Special Emphasis Panel, Conference
and Meetings: Office of Research
Certificate, Application for Merchant
Time: 10:00 a.m. to 1:00 p.m.
Infrastructure Programs (ORIP). Mariner Medical Certificate for Entry
Agenda: To review and evaluate contract
Date: November 10, 2015 Level Ratings, Small Vessel Sea Service
proposals.
Time: 1:00 p.m. to 3:00 p.m. Form, DOT/USCG Periodic Drug Testing
Place: National Institutes of Health, Room
Agenda: To review and evaluate grant Form, Disclosure Statement for
8F100, 5601 Fishers Lane, Rockville, MD applications Narcotics, DWI/DUI, and/or Other
20892, (Telephone Conference Call). Place: National Institutes of Health, 6701 Convictions, Merchant Mariner Medical
Contact Person: P. Chris Roberts, Ph.D., Rockledge Drive, Bethesda, MD 20892, Certificate, Recognition of Foreign
Scientific Review Officer, Scientific Review (Telephone Conference Call).
Program, Division of Extramural Activities,
Certificate. Our ICR describes the
Contact Person: Cathleen L Cooper, Ph.D.,
Room 3G22, National Institutes of Health/ Scientific Review Officer, Center for
information we seek to collect from the
NIAID, 5601 Fishers Lane, MSC 9823, Scientific Review, National Institutes of public. Before submitting this ICR to
Bethesda, MD 20892–7616, 240–669–5053, Health, 6701 Rockledge Drive, Room 2130, OIRA, the Coast Guard is inviting
paul.roberts@nih.gov. MSC 7720, Bethesda, MD 20892, 301–443– comments as described below.
4512, cooperc@csr.nih.gov. DATES: Comments must reach the Coast
(Catalogue of Federal Domestic Assistance Name of Committee: Center for Scientific
Program Nos. 93.855, Allergy, Immunology, Guard on or before December 14, 2015.
Review Special Emphasis Panel, Member
and Transplantation Research; 93.856, Conflict: Vascular and Hematology. ADDRESSES: You may submit comments
Microbiology and Infectious Diseases Date: November 12–13, 2015. identified by Coast Guard docket
Research, National Institutes of Health, HHS) Time: 10:30 a.m. to 7:00 p.m. number [USCG–2015–0694] to the Coast
Dated: October 8, 2015.
Agenda: To review and evaluate grant Guard using the Federal eRulemaking
applications. Portal at http://www.regulations.gov.
Michelle Trout, Place: National Institutes of Health, 6701
mstockstill on DSK4VPTVN1PROD with NOTICES

See the ‘‘Public participation and
Program Analyst, Office of Federal Advisory Rockledge Drive, Bethesda, MD 20892, request for comments’’ portion of the
Committee Policy. (Virtual Meeting). SUPPLEMENTARY INFORMATION section for
[FR Doc. 2015–26125 Filed 10–14–15; 8:45 am] Contact Person: Anshumali Chaudhari,
Ph.D., Scientific Review Officer, Center for
further instructions on submitting
BILLING CODE 4140–01–P Scientific Review, National Institutes of comments.
Health, 6701 Rockledge Drive, Room 4124, A copy of the ICR is available through
MSC 7802, Bethesda, MD 20892 (301) 435– the docket on the Internet at http://
1210, chaudhaa@csr.nih.gov www.regulations.gov. Additionally,

VerDate Sep<11>2014 17:19 Oct 14, 2015 Jkt 238001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\15OCN1.SGM 15OCN1

Document Created: 2018-02-27 08:52:06
Document Modified: 2018-02-27 08:52:06

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		November 6, 2015.
FR Citation		80 FR 62078

80 FR 62078 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 199 (October 15, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health